Udeshi ND, Pedram K, Svinkina T, et al. Antibodies to biotin enable large-scale detection of biotinylation sites on proteins. Nat Methods. 2017;14(12):1167-1170. doi:10.1038/nmeth.4465
Bryson DI, Fan C, Guo LT, Miller C, Söll D, Liu DR. Continuous directed evolution of aminoacyl-tRNA synthetases. Nat Chem Biol. 2017;13(12):1253-1260. doi:10.1038/nchembio.2474
Walther TC, Chung J, Farese RV. Lipid Droplet Biogenesis. Annu Rev Cell Dev Biol. 2017;33:491-510. doi:10.1146/annurev-cellbio-100616-060608
Asano SM, Gao R, Wassie AT, Tillberg PW, Chen F, Boyden ES. Expansion Microscopy: Protocols for Imaging Proteins and RNA in Cells and Tissues. Curr Protoc Cell Biol. 2018;80(1):e56. doi:10.1002/cpcb.56
Zaytouni T, Tsai PY, Hitchcock DS, et al. Critical role for arginase 2 in obesity-associated pancreatic cancer. Nat Commun. 2017;8(1):242. doi:10.1038/s41467-017-00331-y
Abascal F, Juan D, Jungreis I, et al. Loose ends: almost one in five human genes still have unresolved coding status. Nucleic Acids Res. 2018;46(14):7070-7084. doi:10.1093/nar/gky587
Ganna A, Satterstrom K, Zekavat SM, et al. Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum. Am J Hum Genet. 2018;102(6):1204-1211. doi:10.1016/j.ajhg.2018.05.002
Buisson R, Lawrence MS, Benes CH, Zou L. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition. Cancer Res. 2017;77(17):4567-4578. doi:10.1158/0008-5472.CAN-16-3389
Iniguez AB, Alexe G, Wang EJ, et al. Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling. Cancer Cell. 2018;34(6):922-938.e7. doi:10.1016/j.ccell.2018.11.005
Buskirk AR, Liu DR. Creating small-molecule-dependent switches to modulate biological functions. Chem Biol. 2005;12(2):151-61. doi:10.1016/j.chembiol.2004.11.012